Comparative studies of oxaliplatin-based platinum( iv ) complexes in different in vitro and in vivo tumor models - Metallomics (RSC Publishing) DOI:10.1039/C6MT00226A
Johnson Matthey on Twitter: "It's 40 years since the first platinum anti-cancer drug #cisplatin was approved by the US FDA. @compoundchem takes a look at the impact this drug has had on
Studies on Combination of Platinum Drugs Cisplatin and Oxaliplatin with Phytochemicals Anethole and Curcumin in Ovarian Tumour Models | Anticancer Research
Spectrophotometric determination of cisplatin, carboplatin and oxaliplatin in pure and injectable dosage forms
Oxaliplatin. Molecular model of the platinum-based drug oxaliplatin (C8.H14.N2.O4.Pt), used in cancer chemotherapy. Atoms are represented as spheres and are colour-coded: carbon (grey), platinum (small light grey sphere, centre), hydrogen (white ...
Identification of drug transporters contributing to oxaliplatin‐induced peripheral neuropathy - Fujita - 2019 - Journal of Neurochemistry - Wiley Online Library
GALACTOSE CONJUGATED PLATINUM (II) COMPLEX – Sugar Metabolism in Cancer Cells: The Warburg Effect
Eloxatine | C8H16N2O4Pt | CID 5310940 - PubChem
Novel aspects of the preclinical pharmacology of platinum compounds
Oxaliplatin, Platinum anticancer agent (CAS 61825-94-3) (ab141054) | Abcam
IJMS | Free Full-Text | Comparative Study of the Mode of Action of Clinically Approved Platinum-Based Chemotherapeutics
Oxaliplatin | Nature Reviews Drug Discovery
A solid-state 17O NMR study of platinum-carboxylate complexes: carboplatin and oxaliplatin
Platinum Analogs - Pharmacology Flashcards | ditki medical and biological sciences
Synthesis, Structure, and Cytotoxicity of Oxaliplatin-Based Platinum(IV) Anticancer Prodrugs Bearing One Axial Fluoride | Inorganic Chemistry
Structures of the platinum(II) complexes cisplatin, carboplatin and... | Download Scientific Diagram
A solid-state 17O NMR study of platinum-carboxylate complexes: carboplatin and oxaliplatin
Oxaliplatin: pre-clinical perspectives on the mechanisms of action, response and resistance - ecancer
Oxaliplatin in the era of personalized medicine: from mechanistic studies to clinical efficacy | SpringerLink
Frontiers | The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
Oxaliplatin (Lipoxal, NSC 266046, RP 54780, CAS Number: 61825-94-3) | Cayman Chemical
Kinetic Study on the Reactions of Platinum Drugs with Glutathione | Journal of Pharmacology and Experimental Therapeutics
IJMS | Free Full-Text | Nanoparticles Loaded with Platinum Drugs for Colorectal Cancer Therapy
IJMS | Free Full-Text | Comparative Study of the Mode of Action of Clinically Approved Platinum-Based Chemotherapeutics
The side effects of platinum-based chemotherapy drugs: a review for chemists - Dalton Transactions (RSC Publishing) DOI:10.1039/C8DT00838H
Platinum drug adducts. Intra-strand platinum adducts between two... | Download Scientific Diagram
Structure formulas of platinum-complexes. Cisplatin, Carboplatin, and... | Download Scientific Diagram
